Quote | Poseida Therapeutics Inc. (NASDAQ:PSTX)
Last: | $2.77 |
---|---|
Change Percent: | -11.16% |
Open: | $2.69 |
Close: | $2.77 |
High: | $3 |
Low: | $2.685 |
Volume: | 2,854,486 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
News | Poseida Therapeutics Inc. (NASDAQ:PSTX)
2024-05-01 14:28:11 ET A California-based %Biotech company is turning heads on Wednesday after it announced that it entered into a research collaboration and license agreement with Astellas Pharma’s Xyphos Biosciences subsidiary. Shares of %PoseidaTherapeutics (Nasdaq: $P...
2024-05-01 13:54:38 ET Poseida Therapeutics ( NASDAQ: PSTX ) shares traded higher on Wednesday after the company and Japanese drugmaker Astellas ( OTCPK:ALPMY ) announced a partnership to develop and commercialize CAR-T cell therapies for cancer.... Read the full article o...
Message Board Posts | Poseida Therapeutics Inc. (NASDAQ:PSTX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PSTX News Article - Poseida Therapeutics to Present at BofA Securities 2023 Health Car | whytestocks | investorshangout | 05/01/2023 3:20:47 PM |
Link to webcast https://wsw.com/webcast/cc/pstx5/1465560 | jondoeuk | investorshub | 03/20/2023 8:57:39 PM |
R&D Day PR https://www.prnewswire.com/news-releases/poseida-therapeutics-hosts-t | jondoeuk | investorshub | 03/20/2023 8:56:10 PM |
whytestocks: $PSTX News Article - Poseida Therapeutics to Present at H.C. Wainwright Cell Therapy Vi | whytestocks | investorshangout | 02/14/2023 9:10:45 PM |
whytestocks: $PSTX News Article - 7 Penny Stocks To Watch With Unusual Options Activity, December 20 | whytestocks | investorshangout | 12/01/2022 7:25:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Poseida Therapeutics Inc. Company Name:
PSTX Stock Symbol:
NASDAQ Market:
2024-05-01 14:28:11 ET A California-based %Biotech company is turning heads on Wednesday after it announced that it entered into a research collaboration and license agreement with Astellas Pharma’s Xyphos Biosciences subsidiary. Shares of %PoseidaTherapeutics (Nasdaq: $P...
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology PR Newswire - Leverages Poseida's proprietary allogeneic CAR-T platform to develop innovative convertibleCAR ® programs tar...
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting PR Newswire Company to deliver three oral and three poster presentations highlighting its portfolio of non-viral genetic medicines Present...